Home › Funds › IRIDIAN ASSET MANAGEMENT LLC/CT › AXSM

IRIDIAN ASSET MANAGEMENT LLC/CT position in AXSM

AXSOME THERAPEUTICS INC. · Health Care

IRIDIAN ASSET MANAGEMENT LLC/CT reported holding 45,129 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$8.3M, representing 3.03% of its reported portfolio and ranking #9 among its reported holdings. IRIDIAN ASSET MANAGEMENT LLC/CT has disclosed AXSM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)45.13K sh
Reported value held$8.32M
Portfolio Weight3.03%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How IRIDIAN ASSET MANAGEMENT LLC/CT's AXSM position evolved

IRIDIAN ASSET MANAGEMENT LLC/CT first disclosed a stake in AXSM in Q3 2023 at 145,033 shares (US$10.1M). The position peaked in Q4 2025 at 73,783 shares, worth US$13.5M. Across 13 filings, IRIDIAN ASSET MANAGEMENT LLC/CT increased the stake 0 time(s), trimmed it 11 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 45,129 shares valued at US$8.3M — a reduction of -2,795 shares quarter over quarter.. Notable position changes include a 29% trim in Q2 2026 (shares fell 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 145.03K $10.14M New
Q4 2023 138.34K $11.01M Reduce
Q1 2024 128.84K $10.28M Reduce
Q2 2024 126.91K $10.22M Reduce
Q3 2024 126.80K $11.40M Hold
Q4 2024 125.08K $10.58M Reduce
Q1 2025 106.31K $12.40M Reduce
Q2 2025 91.76K $9.58M Reduce
Q3 2025 83.55K $10.15M Reduce
Q4 2025 73.78K $13.48M Reduce
Q1 2026 67.49K $11.41M Reduce
Q2 2026 47.92K $11.73M Reduce
Q3 2026 45.13K $8.32M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AXSM and 13F data

AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 50 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$171.3M), ALETHEA CAPITAL MANAGEMENT, LLC (US$119.7M), Hood River Capital Management LLC (US$98.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AXSM

All AXSM fund holders →

FAQ

How long has IRIDIAN ASSET MANAGEMENT LLC/CT held AXSM?

IRIDIAN ASSET MANAGEMENT LLC/CT has disclosed AXSM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is IRIDIAN ASSET MANAGEMENT LLC/CT's current position in AXSM?

As of Q3 2026, IRIDIAN ASSET MANAGEMENT LLC/CT holds 45.13K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $8.32M, representing 3.03% of its reported portfolio and ranking #9.

Has IRIDIAN ASSET MANAGEMENT LLC/CT been buying or selling AXSM?

In the latest 13F filing (Q3 2026), IRIDIAN ASSET MANAGEMENT LLC/CT reduced its position in AXSM. The position peaked in Q4 2025 at 73.78K shares.

Which other funds hold AXSM?

Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Hood River Capital Management LLC, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.